E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing

E.F. Hutton & Co. served as exclusive financial advisor and placement agent for a strategic business combination between Glucotrack, Inc. and Lōkahi Therapeutics, along with a $5.7 million convertible note financing. The transaction creates a publicly traded healthcare platform combining Lōkahi's AI-driven asset sourcing capabilities with Glucotrack's Nasdaq listing, with Lōkahi becoming the operating company and Glucotrack's CBGM business continuing as a subsidiary.